About the Product

Description


Dorityle 250 Injection containing Doripenem is used for the management of severe bacterial infections. It helps provide broad-spectrum antibacterial coverage and supports effective infection control in critical care settings.

Doripenem works as a carbapenem antibiotic that inhibits bacterial cell wall synthesis, thereby helping eliminate susceptible bacteria effectively.

The injection is widely prescribed in hospital and intensive care settings for complicated respiratory, urinary tract, abdominal, and systemic bacterial infections, leading to consistent institutional demand.

With increasing prevalence of resistant bacterial infections and growing demand for advanced injectable antibiotics, this product offers strong business potential for retailers and distributors. Its broad-spectrum antibacterial action, strong clinical relevance, and steady market demand make it a reliable product for growth in the critical care segment.

Some patients may experience nausea, diarrhea, headache, injection site reactions, rash, or dizziness. Rarely, seizures, severe allergic reactions, or antibiotic-associated colitis may occur and require immediate medical attention.

Dorityle 250 Injection is indicated for complicated urinary tract infections, intra-abdominal infections, hospital-acquired pneumonia, ventilator-associated pneumonia, and other serious bacterial infections caused by susceptible organisms. It helps eliminate resistant bacteria and supports faster clinical recovery.

This injection should be administered strictly under medical supervision by qualified healthcare professionals. Use cautiously in patients with kidney disorders, seizure history, or beta-lactam allergy. Complete the full prescribed course to prevent antibiotic resistance.

Store below 25°C, protected from moisture and direct sunlight. Keep the vial in its original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Doripenem 250mg Injection in the PCD pharma franchise market?

Doripenem 250mg Injection is a high-end carbapenem antibiotic used in serious hospital-acquired infections, making it a specialty critical-care product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include Doripenem Injection in their product range?

Medical distributors and wholesalers can benefit from consistent demand in ICU and hospital settings for complicated infections such as pneumonia, intra-abdominal infections, urinary tract infections, and multi-drug resistant bacterial cases. It is strictly used under hospital supervision.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Doripenem 250mg Injection with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this antibiotic product?

Wholesalers and medical agencies benefit from high-value hospital procurement, ICU-based demand, and steady institutional antibiotic sales when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Doripenem Injection?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this critical antibiotic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.